English
Home > Products > 96-34-4

China 96-34-4 Factory

Our company promises all users of the first-class products and the most satisfying post-sale service. We warmly welcome our regular and new customers to join us for 96-34-4,CAS NO 96-34-4,Methyl chloroacetate, we could solve our customer problems asap and do the profit for our customer. For those who need excellent company and top quality , pls choose us , thanks !
96-34-4, Our goods have been obtained more and more recognition from foreign clients, and established long term and cooperative relationship with them. We`ll offer the best service for every customer and sincerely welcome friends to work with us and establish the mutual benefit together.

Related Products

Hot Products

  • Benzotriazole-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate

    Benzotriazole-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate

    Product Name:Benzotriazole-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate
    Molecular Formula:C18H28F6N6OP2
    Molecular Weight:520.39
    CAS Registry Number:128625-52-5
  • Methyl 3-oxocyclobutanecarboxylate

    Methyl 3-oxocyclobutanecarboxylate

    Product Name:Methyl 3-oxocyclobutanecarboxylate
    Molecular Formula:C6H8O3
    Molecular Weight:128.13
    CAS Registry Number:695-95-4
  • 3-Aminopyridine

    3-Aminopyridine

    Product Name:3-Aminopyridine
    Molecular Weight:94.12
    CAS Registry Number:654671-78-0
  • 2,4-Difluorobenzaldehyde

    2,4-Difluorobenzaldehyde

    Product Name:2,4-Difluorobenzaldehyde
    Molecular Formula:C7H4F2O
    Molecular Weight:142.1
    CAS Registry Number:1550-35-2
  • Spironolactone

    Spironolactone

    Product Name:Spironolactone
    Molecular Formula:C24H32O4S
    Molecular Weight;416.58
    CAS Registry Number;52-01-7
  • Etomidate

    Etomidate

    Product Name:Etomidate
    Molecular Formula:C14H16N2O2
    Molecular Weight;244.29
    CAS Registry Number;33125-97-2
  • Related Blog
  • Reviews

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

CAS NO 96-34-4

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept